We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

10 hedge funds and large institutions have $250K invested in Apollo Endosurgery, Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more capital invested

Capital invested by funds: $111K → $250K (+$139K)

9% less funds holding

Funds holding: 1110 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q3 2016 in Review

10 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2016, worth a combined $250K — up 125% from $111K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of APEN and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $42.4K. The largest seller was UBS Group, exiting entirely with an estimated $6K sold.

  • 10 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2016, down from 11 in Q2 2016.
  • Funds reported $250K of Apollo Endosurgery, Inc. stock for Q3 2016, up 125% quarter-over-quarter.
  • 2 funds opened new Apollo Endosurgery, Inc. positions in Q3 2016 and 3 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $42.4K added.
  • The largest Apollo Endosurgery, Inc. seller in Q3 2016 was UBS Group, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2016.